Ads
related to: weight loss clinical trials participants neededfuturhealth.com has been visited by 100K+ users in the past month
Search results
Results From The WOW.Com Content Network
According to research by the Kaiser Family Foundation, about 1 in 8 adults in the U.S. has taken a GLP-1 drug to treat diabetes, promote weight loss or prevent heart attacks or strokes (in those ...
A more recent 2024 study — also funded by Novo Nordisk — is currently the longest clinical trial on semaglutide for weight loss. It looked at almost 18,000 participants with excess weight or ...
In clinical trials supported by Novo Nordisk, gallstones were reported in 1.5 percent of participants taking a 0.5 mg dose of semaglutide and 0.4 percent of those taking the 1 mg dose. No cases of ...
A 2021 clinical trial found that participants taking semaglutide lost an average of 14.9 percent of their body weight after 68 weeks, compared to 2.4 percent of those taking a placebo. What’s ...
In a 2023 randomized clinical trial, 783 participants took tirzepatide (the generic name for Mounjaro and Zepbound) for 36 weeks. Those who stayed on the drug until week 52 lost an additional 5% ...
The National Weight Control Registry is a research study that includes people (18 years or older) who have lost at least 13.6 kg (30 lbs) of weight and kept it off for at least one year. There are currently over 10,000 members enrolled in the study, making it perhaps the largest study of weight loss ever conducted.
Ads
related to: weight loss clinical trials participants needed